Skip to main content

S. Korea OKs stem cells again

After a three-year moratorium on human stem cell research, South Korean officials gave the go-ahead to a new research project involving human eggs today (Apr. 29) provided that the research meets certain provisos. A national bioethics committee effectively banned research using human eggs in 2006 after Hwang Woo-Suk, a leading stem cell researcher formerly at Seoul National University who claimed to have created the first human stem cells from cloning, was shown to have manipulated and falsifie

Written byElie Dolgin
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
After a three-year moratorium on human stem cell research, South Korean officials gave the go-ahead to a new research project involving human eggs today (Apr. 29) provided that the research meets certain provisos. A national bioethics committee effectively banned research using human eggs in 2006 after Hwang Woo-Suk, a leading stem cell researcher formerly at Seoul National University who claimed to have created the first human stem cells from cloning, was shown to have manipulated and falsified his data. South Korean officials had not granted a single stem cell research license since then. But now, a team led by Chung Hyung-min at Seoul's Cha General Hospital has been granted approval to use human eggs on four conditions: The researchers must set up an Institutional Review Board to prevent fraud and bioethics violations, focus on lab animals to minimize the use of human eggs, secure renewed written consent from egg donors, and remove references to cures in the project's title to avoid giving people a false sense of hope. "This research that we have conditionally approved today is really just the very first step towards a new academic study," said Roh Jae-Kyung, the bioethics committee chief, according to__ linkurl:AFP.;https://www.google.com/hostednews/afp/article/ALeqM5iULRF0jWhoCmJjw2SjKkp6daFIjQ __"Though we hope this will eventually become a ray of hope for those patients with an incurable disease, we want you to refrain from premature or excessive expectations." Hwang is currently on trial for fraud, embezzlement, ethics breaches, and other charges.
**__Related stories:__***linkurl:Hwang Woo-suk's new pet project;https://www.the-scientist.com/blog/display/54648/
[15th May 2008]*linkurl:All Hwang human cloning work fraudulent;https://www.the-scientist.com/news/display/22933/
[10th January 2006]*linkurl:Hwang faked results, says panel;https://www.the-scientist.com/article/display/22870/
[23rd December 2005]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo